Serum biomarkers of cardiovascular complications in COVID-19
The coronavirus disease 2019 (COVID-19) affects not only the respiratory system, but also the cardiovascular system in 20-28% of cases, causing endothelial dysfunction, vasculitis, hyper- and hypocoagulation, myocarditis, endothelial dysfunction and other adverse effects. The presence of cardiovascu...
Saved in:
| Main Authors: | R. M. Gumerov, D. F. Gareeva, P. A. Davtyan, R. F. Rakhimova, T. I. Musin, Sh. Z. Zagidullin, A. E. Pushkareva, M. R. Plotnikova, V. Sh. Ishmetov, V. N. Pavlov, L. J. Motloch, N. Sh. Zagidullin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2021-07-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/4456 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction
by: D. F. Gareeva, et al.
Published: (2020-12-01) -
Is anticoagulant therapy necessary after hospitalization with COVID-19 pneumonia?
by: P. A. Davtyan, et al.
Published: (2022-02-01) -
Analysis of distant cardiovascular events depending on the biomarker profile in patients with myocardial infarction
by: A. F. Khamitova, et al.
Published: (2019-04-01) -
Role of Lipid-Rich Plaques in Outcomes of Drug-Eluting Stent Implantation in Patients with Coronary Artery Disease
by: I. A. Mustafina, et al.
Published: (2019-03-01) -
HEART RATE TURBULENCE AS A MORTALITY PREDICTOR IN LONG-TERM STUDY IN PATIENTS WITH CORONARY HEART DISEASE
by: D. Gareeva, et al.
Published: (2016-04-01)